Urgent

Intravenous immunoglobulin infusion reaction

Adverse reactions during IVIG/immunoglobulin therapy · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Reactions to immunoglobulin therapy are usually rate-related (headache, flushing, myalgia, fever, chest tightness) and settle with slowing the infusion, but anaphylaxis can occur, particularly in IgA-deficient patients with anti-IgA antibodies. Serious delayed complications include aseptic meningitis, thrombosis, haemolysis and acute kidney injury.

Red flags

  • Wheeze, hypotension or angioedema (anaphylaxis)
  • Severe headache with neck stiffness (aseptic meningitis)
  • Chest pain, dyspnoea or focal deficit (thrombosis)
  • Dark urine / falling haemoglobin (haemolysis)
  • Oliguria or rising creatinine (acute kidney injury)

Assessment

Differential diagnosis

  • Rate-related infusion reaction (most common)
  • True anaphylaxis (anti-IgA antibodies in IgA deficiency)
  • Aseptic meningitis (delayed)
  • Haemolytic reaction from isoagglutinins
  • Volume overload / thrombosis

Investigations

  • Observations and continuous monitoring during infusion
  • FBC and haptoglobin/LDH if haemolysis suspected
  • Renal function (acute kidney injury with sucrose-containing products)
  • IgA level and anti-IgA antibodies if recurrent/anaphylactic reactions
  • Tryptase if anaphylaxis suspected

Management

  • For mild rate-related symptoms, slow or pause the infusion and observe
  • Give paracetamol and antihistamine for headache, flushing and fever
  • Resume at a slower rate once symptoms settle
  • For anaphylaxis, stop the infusion and treat with IM adrenaline, oxygen and fluids
  • Ensure adequate hydration to reduce thrombosis and renal risk
  • Investigate IgA deficiency/anti-IgA antibodies after a severe reaction and use IgA-depleted product
  • Pre-medicate and reduce infusion rate for subsequent cycles if prior reactions
  • Consider switching to subcutaneous immunoglobulin for recurrent systemic reactions

Drugs & doses

Paracetamol — 1 g orally/IV as premedication and symptom relief
Chlorphenamine — 10 mg IV/IM for flushing/urticaria
Hydrocortisone — 100-200 mg IV for moderate-severe reactions
Adrenaline IM — 500 mcg (0.5 mL 1:1000) for anaphylaxis
0.9% sodium chloride — IV hydration to reduce thrombotic/renal risk

Disposition

Continue monitored infusion after mild reactions; admit anaphylaxis or serious complications and review product choice/route before the next cycle.

Complications & pitfalls

  • Anaphylaxis in IgA-deficient recipients
  • Aseptic meningitis
  • Thromboembolism (arterial and venous)
  • Haemolytic anaemia from isoagglutinins
  • Acute kidney injury and volume overload

Exam pearls

  • Most reactions are rate-related and respond to slowing the infusion
  • Suspect anti-IgA antibodies in anaphylaxis — check IgA and use IgA-depleted product
  • Keep patients well hydrated to mitigate thrombotic and renal risk
  • Subcutaneous immunoglobulin has fewer systemic reactions for recurrent reactors

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.